Roland Meisel

Roland Meisel, Ph.D., is the Chief Commercial Officer at Keystonemab and has served as CEO and Founder of BLAC-BioPharma GmbH since March 2016, a consultancy specializing in the licensing of Biologics with a focus on Biosimilars. Additionally, Meisel is a Partner at Weissknight Corporate Finance, which aids business owners in enhancing company value through international M&A transactions and business optimization strategies. From August 2019 to July 2024, Meisel held the position of Vice President of Business Development & Licensing ex-China at Biotheus, overseeing licensing and co-development agreements. Other significant roles include Managing Director of Technical Operations at Saudi Biotechnology Manufacturing Co. and global Business Development responsibilities at The Biosimilars Group. Meisel's educational background includes a Ph.D. in Chemistry from Universität Rostock and graduate studies in carbohydrate chemistry at Purdue University.